The committee for advanced therapies' of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesis. (2013)

First Author: Aiuti A
Attributed to:  MICA: MRC Centre for Neuromuscular Diseases funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 23862696

Publication URI:

Type: Journal Article/Review

Volume: 24

Parent Publication: Human gene therapy. Clinical development

Issue: 2

ISSN: 2324-8637